Sepracor appears to have almost stopped advertising for sleeping pill Lunesta, and yet sales are still rising. Sepracor spent less than $1 million on ads for the brand in 2009, but Lunesta sales were up 2 percent to $151 million in Q2 2009. by Jim Edwards
Some Sepracor shareholders have sued the company's board alleging that their acceptance of Dainippon Sumitomo's acquisition offer of $23 a share, a premium of just 27.6 percent, isn't such a great deal. BNET suggested this might happen on Sept. 3. Other attorneys are trawling for clients for...
Some Sepracor shareholders have sued the company's board alleging that their acceptance of Dainippon Sumitomo's acquisition offer of $23 a share, a premium of just 27.6 percent, isn't such a great deal. BNET suggested this might happen on Sept. 3. Other attorneys are trawling for clients for...
Holders of Sepracor stock considering Dainippon's offer of $23 a share to take over the company might want to ask themselves, might this company be willing to pay more than a 27.6 percent premium? A brief look at the two companies suggests that Dainippon needs this more than Sepracor, and...
Asked to name the most recession-resistant commodities most people would place "drugs" in the top spot. Indeed demand for certain prescription drugs -- especially those that treat seemingly recession-related maladies like insomnia -- has spiked over the last two years. According to data published by IMS Health (RX) a market research firm that specializes in health care prescriptions for sleeping pills -- such as Ambien from "I've never seen any decline in demand for marijuana in bad economic times " said Ed Shemelya head of marijuana eradication for the Office of Drug Control Policy’s Appalachian High Intensity Drug Trafficking ...
Below are interesting stocks on the NASDAQ and NYSE with the highest ROE.
Noble Corp (ticker: NE) has a return over equity of 29.48 and the PEG ratio of 0.78. Oppenheimer initiated coverage of NE with a “perform” rating.
Sepracor Inc (ticker: SEPR) has a return over equity of 29.48 and the PEG ratio of 0.78. SEPR posted its EPS for the June quarter significantly ahead of expectations.
InterDigital Inc (ticker: IDCC) has a return over equity of 28.75 and the PEG ratio of 0.75. Hilliard Lyons upgraded IDCC from “neutral” to “buy.”
Today we are featuring top-performing “Small-Cap” equity mutual funds, which primarily invest in equity securities of companies that have market capitalizations of less than $2 billion.
Investors can find such funds by checking out the entire list of the Zacks #1 Rank Small-Cap Equity Funds.
2 Solid Picks
Dean Small Cap Value A (DASCX) seeks long-term capital [...]
Today, Dainippon Sumitomo and Sepracor (SEPR) have announced the successful completion of the initial share offering period, where almost 78.2% of Sepracor’s shares were tendered. The offer period has been extended to Oct 19, 2009, to enable other shareholders to tender their shares as well.
As a reminder, in September, the Japanese pharmaceutical company Dainippon Sumitomo [...]
Today we are featuring top-performing “Small-Cap” equity mutual funds, which primarily invest in equity securities of companies that have market capitalizations of less than $2 billion.
Investors can find such funds by checking out the entire list of the Zacks #1 Rank Small-Cap Equity Funds.
3 Solid Choices
Buffalo Small Cap (BUFSX) seeks long-term growth of capital. [...]
Bristol Myers Squibb (BMY) yesterday announced that it would sell the Asian rights to its over-the-counter (OTC) drugs to Japan’s Taisho Pharmaceutical for $160 million. Taisho will also buy Bristol’s Indonesian unit, which manufactures and sells OTC and ethical pharmaceutical products, for $150 million. The deal is expected to close during the fourth quarter [...]
BloggingStocks: From TheStreet.com Network
More ETFs Get Sued
Kraft Seeking Financing for Cadbury Bid
TheStreet.com's Jim Cramer says the action that is linked to the futures markets, such as oil, is distorting rational analysis. Maybe one day we can ... Read more
Get daily news and insights for the advertising, automotive, energy, financial services, food, health care, media, pharmaceutical, retail, technology, and travel industries.
